as on October 30, 2025 at 1:29 am IST
Day's Low
Day's High
1.49%
Downside
3.98%
Upside
52 Week's Low
52 Week's High
42.15%
Downside
1554.23%
Upside
Check Jaguar Health Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.6M
EPS (TTM)
-23.81
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.05
Industry PE ratio
0PEG Ratio
-0.02
EBITDA
-30.9M
Revenue (TTM)
11.8M
Profit Margin
0.00%
Return On Equity TTM
-319.25%
Track how Jaguar Health Inc P/E has moved over time to understand its valuation trends.
Jaguar Health Inc in the last 5 years
Lowest (-97.83x)
September 30, 2023
Industry (0.00x)
October 29, 2025
Today (0.05x)
October 29, 2025
Highest (-0.04x)
June 30, 2025
Today’s Price to Earnings Ratio: 0.05x
Compare market cap, revenue, PE, and other key metrics of Jaguar Health Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $7.6M | -100% | 0.05 | 0.00% | |
| BUY | $62.7B | 285.91% | -505.15 | -12.96% | |
| NA | $36.5B | NA | NA | -3.89% | |
| BUY | $108.0B | 104.04% | 29.95 | 31.86% | |
| BUY | $62.0B | 17.76% | 14.75 | 31.37% |
The Jaguar Health Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Jaguar Health Inc investment value today
Current value as on today
₹12,506
Returns
Returns from Jaguar Health Inc Stock
Dollar Returns*
₹5,061 (+5.06%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Jaguar Health Inc. Average target price of $25.5
Get share price movements and forecasts by analysts on Jaguar Health Inc.
What analysts predicted
92.12%UPSIDE
Target Price
$25.5
Current Price
$2.01
Analyzed by
7 Analysts
Target
$25.50
Jaguar Health Inc target price $25.5, a slight upside of 92.12% compared to current price of $2.01. According to 7 analysts rating.
Search interest for Jaguar Health Inc Stock has increased by 129% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:129% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -10.46M → -10.40M (in $), with an average increase of 0.6% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 2.17M → 2.97M (in $), with an average increase of 27.1% per quarter
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.1% return, outperforming this stock by 161.3%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.7% return, outperforming this stock by 232.7%
Price Dip
![]()
In the last 6 months, JAGX stock has moved down by -83.2%
| Organisation | Jaguar Health Inc |
| Headquarters | 200 Pine Street, San Francisco, CA, United States, 94104 |
| Industry | Health Technology |
| CEO | Ms. Lisa A. Conte |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Carol R. Lizak M.B.A. | Chief Financial Officer |
Dr. Karen J. Brunke Ph.D. | Executive VP of Corporate & Business Development |
Dr. Massimo Radaelli M.B.A., Ph.D. | President of Jaguar International |
Ms. Lisa A. Conte | Founder, CEO, President & Director |
Mr. Jonathan S. Wolin CPA, J.D., M.B.A. | Chief of Staff, Chief Compliance Officer & General Counsel |
Dr. Steven R. King Ph.D. | Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary |
Mr. Ian H. Wendt M.B.A. | Chief Commercial Officer |
Dr. Pravin R. Chaturvedi Ph.D. | Chief Scientific Officer & Chair of Scientific Advisory Board |
Mr. Peter Hodge | Senior Director of Investor Relations, Business Development & Special Events |
Mr. David Sesin Ph.D. | Chief Manufacturing Officer |
Jaguar Health Inc share price today is $2.01 as on at the close of the market. Jaguar Health Inc share today touched a day high of $2.09 and a low of $1.98.
Jaguar Health Inc share touched a 52 week high of $33.25 on and a 52 week low of $1.16 on . Jaguar Health Inc stock price today i.e. is closed at $2.01,which is 93.95% down from its 52 week high and 72.86% up from its 52 week low.
Jaguar Health Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Jaguar Health Inc (JAGX) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Jaguar Health Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Jaguar Health Inc share’s latest price of $2.01 as on October 30, 2025 at 1:29 am IST, you will get 4.9751 shares of Jaguar Health Inc. Learn more about
fractional shares .
Jaguar Health Inc stock has given -100% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?